About Us

Leadership

David Schenkein
David Schenkein
Chief Executive Officer
Scott Biller
Scott Biller, Ph.D.
Chief Scientific Officer
Chris Bowden
Chris Bowden, M.D.
Chief Medical Officer
John Evans
John Evans
SVP Corporate Development and Portfolio Leadership
Andrew Hirsch
Andrew Hirsch
Chief Financial Officer
Steve Hoerter
Steve Hoerter
Chief Commercial Officer
Megan Pace
Megan Pace
SVP Strategic Operations and Communications
Bob Sheroff
Bob Sheroff
SVP Technical Operations
Min Wang
Min Wang, J.D., Ph.D.
SVP Legal and Corporate Secretary
Melissa McLaughlin
Melissa McLaughlin
SVP Human Resources

Board of Directors

Lewis C. Cantley
Co-Founder
Maykin Ho, Ph.D.
Independent
David Schenkein, M.D.
Agios Pharmaceuticals
Paul Clancy
Biogen
Kaye Foster
Independent
Bob Nelsen
ARCH Venture Partners
Ian Clark
Independent
John Maraganore, Ph.D.
Alnylam Pharmaceuticals

Founders

Lewis C. Cantley

Director of the Cancer Center at Weill Cornell Medical College and New York-Presbyterian Hospital; member of the National Academy of Sciences and American Academy of Arts and Sciences

/ read more /
Tak W. Mak, Ph.D.

Professor of Medical Biophysics, University of Toronto; Director of the Advanced Medical Discovery Institute; Director of the Campbell Family Institute for Breast Cancer Research; foreign associate of the National Academy of Sciences and fellow of the Royal Society.

/ read more /
Shin-San Michael Su, Ph.D.

Chief Scientific Officer at Decibel Therapeutics

/ read more /
Craig B. Thompson, M.D.

President and CEO of Memorial Sloan-Kettering Cancer Center; member of the National Academy of Sciences, American Academy of Arts and Sciences and Institute of Medicine

/ read more /

Scientific Advisors

Agios has assembled a world-class scientific advisory board that includes renowned experts in cancer metabolism, oncology, drug discovery and translational medicine. These advisors work in close collaboration with Agios scientists to identify new research directions and accelerate Agios' target validation and drug discovery programs.

Joan Brugge, Ph.D.
Harvard Medical School
Lewis C. Cantley
The Cancer Center at Weill Cornell Medical College and New York-Presbyterian Hospital
Ralph Deberardinis, M.D., Ph.D.
Children's Medical Center Research Institute at UT Southwestern
Matthew Vander Heiden, M.D., Ph.D.
Koch Institute for Integrative Cancer Research at MIT
William G. Kaelin, M.D.
Dana-Farber Cancer Institute and Harvard Medical School
Tak W. Mak
University of Toronto and the Campbell Family Institute for Breast Cancer Research
Pier Paolo Pandolfi
Beth Israel Deaconess Medical Center
Charles Sawyers
Memorial Sloan-Kettering Cancer Center
Shin-San Michael Su
Former SVP of Research and Development at Agios
Marc Tessler-Lavigne
Stanford University
Craig B. Thompson, M.D.
Chair of the scientific advisory board, Memorial Sloan-Kettering Cancer Center